Share on LinkedInShare on LinkedIn

ARTICLE · 29 DECEMBER 2025

Executive Order: A Game-Changer For Cannabis And Hemp

Benesch, Friedlander, Coplan & Aronoff LLP
Benesch, Friedlander, Coplan & Aronoff LLP
Contributor
Explore more from Benesch, Friedlander, Coplan & Aronoff LLP

President Trump's new Executive Order (EO) is historic, not only because it directs the rescheduling of cannabis from Schedule I to Schedule III...

United StatesCannabis & Hemp
Alissa Jubelirer
Alissa Jubelirer
Author LinkedIn connections

Key Takeaways

  • President Trump's new Executive Order (EO) is historic, not only because it directs the rescheduling of cannabis from Schedule I to Schedule III, but because it also directs Congress to revise the "hemp ban" language in the 2026 FY Agriculture Appropriations Bill to carve out and protect access to full spectrum CBD and hemp-derived THC products, subject to potency limits and with consideration to cannabinoid ratios and serving size.
  • The details and timeline for cannabis to officially be rescheduled remain uncertain given the stalled rescheduling hearings that began under President Biden. The impact on recreational cannabis is also still unclear. The timeline is more concrete for the hemp industry. They have less than a year to persuade legislators to change the language in the Appropriations Bill to avert a total collapse of the $28.4 billion hemp sector.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests from cannabis sellers, alcohol producers, and state regulators creating policy gridlock, the future of intoxicating hemp products remains uncertain as midterm elections approach.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

The landscape surrounding Section 280E of the Internal Revenue Code continues to evolve with President Trump's Executive Order on medical marijuana rescheduling, advancing litigation in New Mexico Top Organics v. Commissioner, and shifting regulatory signals. Cannabis taxpayers face critical decisions about taking "non-280E" positions on their tax returns while the IRS maintains its enforcement stance and the U.S. Tax Court case addressing common arguments remains pending.
United StatesCannabis & Hemp
Foley Hoag LLP
Foley Hoag LLP
Article

The Coming State-Law Litigation Wave Of 2026-27: “Subscription Trap” Class Actions

State-law class actions targeting automatic renewal and subscription practices are accelerating, creating significant litigation risk for companies that rely on recurring revenue models. Recent settlements demonstrate that even technical compliance failures can lead to seven-figure exposure, with California, Illinois, and Virginia statutes driving the most aggressive litigation.
United StatesConsumer Protection
Benesch, Friedlander, Coplan & Aronoff LLP
Benesch, Friedlander, Coplan & Aronoff LLP
Article

DOJ Announces 2026 National Health Care Fraud Takedown: 455 Defendants Charged In $6.5 Billion Enforcement Action

The Department of Justice's 2026 National Health Care Fraud Takedown charged 455 defendants in connection with $6.5 billion in alleged fraud schemes, marking an unprecedented scale of enforcement action. This whole-of-government approach leverages advanced data analytics and international cooperation to combat healthcare fraud across Medicare, Medicaid, and other federal programs. The enforcement action demonstrates heightened scrutiny of providers, aggressive asset forfeiture, and a focus on cases involvin
United StatesCriminal Law
Benesch, Friedlander, Coplan & Aronoff LLP
Benesch, Friedlander, Coplan & Aronoff LLP
Article

Emerging Enforcement Trends In Digital Health Data Privacy: Lessons From Washington’s My Health My Data, FTC vs. Hims & Hers And UCHealth Enforcement Actions

Federal and state regulators are intensifying scrutiny of healthcare and digital health companies over tracking technologies that share sensitive patient data with advertising platforms. Recent enforcement actions against major telehealth providers and healthcare systems reveal how common marketing practices can trigger significant legal liability under privacy laws, even for organizations not covered by HIPAA.
United StatesPrivacy
Benesch, Friedlander, Coplan & Aronoff LLP
Benesch, Friedlander, Coplan & Aronoff LLP
Article

SEC Publishes The Long-Awaited Regulation Crypto Assets Proposed Rules

The SEC has proposed Regulation Crypto Assets, its most comprehensive digital asset framework to date, establishing exemptions for startups and fundraising while introducing an Investment Contract Safe Harbor that could formally determine when crypto assets are no longer subject to securities laws. As regulators shift from enforcement-focused approaches to clearer rulemaking, agencies continue targeting fraud and misconduct, signaling that compliance remains critical even as the regulatory landscape evolves
United StatesFinance and Banking
Benesch, Friedlander, Coplan & Aronoff LLP
Benesch, Friedlander, Coplan & Aronoff LLP